28.11.2014 Views

European perspectives on global health: a policy glossary

European perspectives on global health: a policy glossary

European perspectives on global health: a policy glossary

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1. Europe must make <strong>global</strong> <strong>health</strong> a priority<br />

Globalisati<strong>on</strong> has a profound<br />

impact up<strong>on</strong> <strong>health</strong><br />

“Globalisati<strong>on</strong> can be defined as the<br />

“widening, deepening and speeding up of<br />

worldwide interc<strong>on</strong>nectedness in all aspects of<br />

c<strong>on</strong>temporary social life”. ( Held, et al 1999 )<br />

“Although resp<strong>on</strong>sibilities for <strong>health</strong> remain<br />

primarily nati<strong>on</strong>al, the determinants of <strong>health</strong><br />

and the means to fulfil that resp<strong>on</strong>sibility are<br />

increasingly <strong>global</strong>.” ( Jamis<strong>on</strong>, et al 1998 )<br />

The relati<strong>on</strong>ship between <strong>global</strong>isati<strong>on</strong> and <strong>health</strong><br />

is a two-way process. There are many direct and<br />

indirect ways in which <strong>global</strong>isati<strong>on</strong> affects <strong>health</strong>.<br />

The inverse is also true : a society which suffers<br />

from a high burden of disease is not in a positi<strong>on</strong> to<br />

participate effectively in the processes of <strong>global</strong>isati<strong>on</strong><br />

and therefore will not be able to share its benefits.<br />

And a <strong>global</strong> disease outbreak can lead to significant<br />

human and financial losses all around the world. The<br />

interface between <strong>global</strong>isati<strong>on</strong> and <strong>health</strong> has all the<br />

ingredients of a vicious spiral, but also the potential<br />

for a virtuous circle. Europe is both affected by and<br />

c<strong>on</strong>tributes to this in manifold ways :<br />

• Globalisati<strong>on</strong> leads to more rapid spread of<br />

<strong>health</strong> problems, as a c<strong>on</strong>sequence of increasing<br />

worldwide travel ( infectious diseases ) as well as<br />

through the spread of c<strong>on</strong>sumpti<strong>on</strong> habits through<br />

<strong>global</strong> marketing ( smoking, changing patterns<br />

of food c<strong>on</strong>sumpti<strong>on</strong> ). Lack of c<strong>on</strong>trol of <strong>global</strong><br />

disease spread can lead to a range of negative<br />

impacts in both rich and poor countries as the<br />

SARS epidemic and spread of obesity show.<br />

• Globalisati<strong>on</strong> has helped to increase scientific<br />

and technological knowledge sharing for the<br />

development of medicines, vaccines and medical<br />

appliances, which allows new forms of treatment<br />

and preventi<strong>on</strong> to develop. It has also improved<br />

communicati<strong>on</strong> and transport possibilities and<br />

thus reduced the technical barriers to access<br />

to medical informati<strong>on</strong> and treatment. Internet<br />

communicati<strong>on</strong> has also drastically improved the<br />

possibility of tracking and m<strong>on</strong>itoring outbreaks of<br />

infectious diseases.<br />

• Access to medical progress has been more<br />

unequal ; as the <strong>health</strong> sector has c<strong>on</strong>tinued<br />

to grow in developed countries, the ec<strong>on</strong>omic<br />

restricti<strong>on</strong>s for the <strong>health</strong> sector in many poor<br />

countries has increased. Reas<strong>on</strong>s include :<br />

pressures <strong>on</strong> public expenditures, sometimes<br />

due to c<strong>on</strong>diti<strong>on</strong>s imposed <strong>on</strong> structural<br />

adjustment loans, increasing prices for newly<br />

developed medical inputs due to more stringent<br />

internati<strong>on</strong>al property rights rules, low research<br />

and development ( R&D ) expenditures <strong>on</strong> many<br />

tropical diseases, d<strong>on</strong>or focus <strong>on</strong> disease-specific<br />

programmes and lack of priority assigned by some<br />

of the countries themselves. Many poor countries<br />

also find it increasingly difficult to retain medical<br />

staff who are attracted by higher salaries in rich<br />

countries.<br />

• The rapid increase in <strong>global</strong> interc<strong>on</strong>nectedness<br />

has also transformed the face of internati<strong>on</strong>al<br />

politics. The growing percepti<strong>on</strong> of security risks<br />

for high-income countries due to <strong>health</strong>, but also<br />

the increasing strength of advocacy organisati<strong>on</strong>s<br />

in this field and the more active role taken by<br />

developing countries in internati<strong>on</strong>al fora and<br />

negotiati<strong>on</strong>s related to <strong>health</strong> has changed the<br />

field of internati<strong>on</strong>al cooperati<strong>on</strong> in <strong>health</strong>. Many<br />

new instituti<strong>on</strong>s have entered the field and the<br />

roles of traditi<strong>on</strong>al instituti<strong>on</strong>s have changed.<br />

• Private actors have rapidly gained importance<br />

as <strong>health</strong> becomes a major <strong>global</strong> market.<br />

Powerful companies and other private for-profit<br />

actors try to defend their strategic positi<strong>on</strong> in<br />

a liberalised <strong>global</strong> trade system ; this includes<br />

food, pharmaceuticals, agricultural products,<br />

insurance companies. Global civil society in turn<br />

has c<strong>on</strong>siderably strengthened its advocacy role<br />

and is increasing the pressure <strong>on</strong> private business<br />

to accept corporate social resp<strong>on</strong>sibility for <strong>global</strong><br />

<strong>health</strong>.<br />

Acti<strong>on</strong> : “Making <strong>global</strong>isati<strong>on</strong> work for every<strong>on</strong>e’s<br />

<strong>health</strong>” should be at the core of a <str<strong>on</strong>g>European</str<strong>on</strong>g> strategy<br />

for <strong>global</strong> <strong>health</strong>.<br />

14 <str<strong>on</strong>g>European</str<strong>on</strong>g> Foundati<strong>on</strong> Centre – <str<strong>on</strong>g>European</str<strong>on</strong>g> Partnership for Global Health

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!